Understanding these therapies can boost performance and longevity
Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes
Carnitine deficiency impairs a variety of metabolic processes in the liver, including lipid metabolism, gluconeogenesis, ketogenesis, albumin biosynthesis, and ammonia detoxification in the urea cycle [201], and carnitine/acetylcarnitine supplementation can ameliorate a variety of liver diseases [202, 203]
If the inflammation is coming from an autoimmune condition, active infection, untreated sleep apnea, heavy alcohol use, or another non-metabolic cause, the effect may be modest or incomplete
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, along with international regulatory bodies, requires extensive stability testing before approving any medication